Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12060471 | 0.87 | — | — | |
| SCHEMBL14768977 | 0.80 | — | — | |
| SCHEMBL14769001 | 0.77 | — | — | |
| SCHEMBL25418019 | 0.76 | — | — | |
| SCHEMBL5675642 | 0.75 | USP2 (0.32) | USP2ALDH1A1LMNACYP1A2TSHR | |
| Hydrochloric Acid SCHEMBL57027 | 0.73 | USP2 (0.31) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL5831969 | 0.73 | — | — | |
| SCHEMBL24324139 | 0.73 | USP2 (0.31) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL13990926 | 0.73 | KDM4E (0.30) | — | |
| SCHEMBL25377362 | 0.73 | USP2 (0.32) | USP2ALDH1A1LMNACYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4448605-B1 | PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4200353-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4200351-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4200352-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-12466913-B2 | Method for the production of a thermoplastic polyoxazolidinone | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-11 | — | — | US | disclosed |
| US-12378348-B2 | Method for the production of a thermoplastic polyoxazolidinone | COVESTRO DEUTSCHLAND AG (DE) | 2025-08-05 | — | — | US | disclosed |
| US-20250043061-A1 | PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-02-06 | — | — | US | disclosed |
| EP-4448605-A1 | PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2024-10-23 | — | — | EP | disclosed |
| EP-4255947-B1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2024-07-03 | — | — | EP | disclosed |
| US-20240026065-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2024-01-25 | — | — | US | disclosed |
| EP-2420491-A1 | 3 , 5-substitued piperidine compounds as renin inhibitors | Novartis AG (CH) | 2012-02-22 | — | — | EP | disclosed |
| US-20090192148-A1 | Organic Compounds | NOVARTIS AG (CH) | 2009-07-30 | — | — | US | disclosed |
| US-20090192148-A1 | Organic Compounds | NOVARTIS AG (CH) | 2009-07-30 | — | — | US | disclosed |
| WO-2007077005-A1 | 3 , 5-SUBSTITΓUED PIPERIDINE COMPOUNDS AS RENIN INHIBITORS | NOVARTIS AG (CH) | 2007-07-12 | — | — | WO | disclosed |
| EP-1454958-B1 | LACTIC ACID POLYMER COMPOSITION AND MOLDED OBJECT THEREOF | NEW JAPAN CHEM CO LTD (JP) | 2006-10-04 | — | — | EP | disclosed |
| US-20050001349-A1 | Lactic acid polymer composition and molded object thereof | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-1454958-A1 | LACTIC ACID POLYMER COMPOSITION AND MOLDED OBJECT THEREOF | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2004-09-08 | — | — | EP | disclosed |
| US-5973076-A | MOLDING; CONTROLLING TEMPERATURE IN PRESENCE OF AN AMIDE COMPOUND | NEW JAPAN CHEMICAL CO., LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0776933-B1 | Polybutene-1 resin composition and a method of accelerating the crystal transformation | NEW JAPAN CHEM CO LTD (JP) | 1999-08-04 | — | — | EP | disclosed |
| EP-0776933-A1 | Polybutene-1 resin composition and a method of accelerating the crystal transformation | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1997-06-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192148-A1 | Organic Compounds | REN, ACE, AGTR1 | SLC6A4 895/4885SLC6A3 428/4885USP2 3964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.